Cargando…

Detection frequencies and viral load distribution of parvovirus B19 DNA in blood and plasma donations in England

BACKGROUND AND OBJECTIVES: Infections with human parvovirus B19 (B19V) are transmissible by blood components and plasma‐derived medicines. The European Pharmacopoeia regulates maximum levels of virus allowed in manufacturers' plasma pools. To evaluate contamination risk prior to re‐introduction...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williams, Sarah, Ratcliff, Jeremy, Nguyen, Dung, Simmonds, Peter, Harvala, Heli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796365/ https://www.ncbi.nlm.nih.gov/pubmed/35751630 http://dx.doi.org/10.1111/tme.12893

Ejemplares similares

Effects of Severe Acute Respiratory Syndrome Coronavirus 2 Strain Variation on Virus Neutralization Titers: Therapeutic Use of Convalescent Plasma
por: Nguyen, Dung, et al.
Publicado: (2021)

Comparison of SARS‐CoV‐2 neutralizing antibody testing of convalescent plasma donations in the Netherlands and England: A pilot study
por: Harvala, Heli, et al.
Publicado: (2021)

Understanding the outcomes of COVID-19 – does the current model of an acute respiratory infection really fit?
por: Simmonds, Peter, et al.
Publicado: (2020)

Evaluating the risk of transfusion and transplant‐transmitted monkeypox infections
por: Harvala, Heli, et al.
Publicado: (2022)

Increase in Enterovirus D68 Infections in Young Children, United Kingdom, 2006–2016
por: Kamau, Everlyn, et al.
Publicado: (2019)

Seroprevalence and Virologic Surveillance of Enterovirus 71 and Coxsackievirus A6, United Kingdom, 2006–2017
por: Kamau, Everlyn, et al.
Publicado: (2021)

Changes in transmission of Enterovirus D68 (EV-D68) in England inferred from seroprevalence data
por: Pons-Salort, Margarita, et al.
Publicado: (2023)

Evaluation of SARS‐CoV‐2 antibody titers and potency for convalescent plasma donation: a brief commentary
por: Wouters, Elise, et al.
Publicado: (2020)

Convalescent plasma for COVID-19: male gender, older age and hospitalisation associated with high neutralising antibody levels, England, 22 April to 12 May 2020
por: Mehew, Jennifer, et al.
Publicado: (2020)

Virological Characterization of Critically Ill Patients With COVID-19 in the United Kingdom: Interactions of Viral Load, Antibody Status, and B.1.1.7 Infection
por: Ratcliff, Jeremy, et al.
Publicado: (2021)

Use of a small DNA virus model to investigate mechanisms of CpG dinucleotide-induced attenuation of virus replication
por: Loew, Lisa, et al.
Publicado: (2020)

Fulminant Transfusion-Associated Hepatitis E Virus Infection Despite Screening, England, 2016–2020
por: Harvala, Heli, et al.
Publicado: (2022)

Mapping of serological testing and SARS-CoV-2 seroprevalence studies performed in 20 European countries, March-June 2020
por: Bubba, Laura, et al.
Publicado: (2021)

Convalescent plasma treatment for SARS-CoV-2 infection: analysis of the first 436 donors in England, 22 April to 12 May 2020
por: Harvala, Heli, et al.
Publicado: (2020)

Investigating Blood Donors With Postdonation Respiratory Tract Symptoms During the Wild-Type, Delta, and Omicron Waves of the Coronavirus Disease 2019 Pandemic in England
por: Gates, Shannah, et al.
Publicado: (2023)

Undeclared pre-exposure or post-exposure prophylaxis (PrEP/PEP) use among syphilis-positive blood donors, England, 2020 to 2021
por: Maddox, Victoria, et al.
Publicado: (2023)

Prevalence of Parvovirus B19 Viremia Among German Blood Donations and the Relationship to ABO and Rhesus Blood Group Antigens
por: Healy, Katie, et al.
Publicado: (2022)

Potential APOBEC-mediated RNA editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution
por: Ratcliff, Jeremy, et al.
Publicado: (2021)

The roles of nucleic acid editing in adaptation of zoonotic viruses to humans
por: Ratcliff, Jeremy, et al.
Publicado: (2023)

Canine Parvovirus Infections and Other Viral Enteritides
por: Sykes, Jane E.
Publicado: (2014)

Hepatitis E virus in blood donors in England, 2016 to 2017: from selective to universal screening
por: Harvala, Heli, et al.
Publicado: (2019)

Human Parvovirus 4 Infection, Cameroon
por: Lavoie, Myriam, et al.
Publicado: (2012)

Association of Zinc Finger Antiviral Protein Binding to Viral Genomic RNA with Attenuation of Replication of Echovirus 7
por: Goonawardane, Niluka, et al.
Publicado: (2021)

Impact of the frequency of plasma viral load monitoring on treatment outcomes among children with perinatally acquired HIV
por: Sudjaritruk, Tavitiya, et al.
Publicado: (2019)

Parenteral Transmission of the Novel Human Parvovirus PARV4
por: Simmonds, Peter, et al.
Publicado: (2007)

Hepatitis E virus is the leading cause of acute viral hepatitis in Lothian, Scotland
por: Kokki, I., et al.
Publicado: (2015)

Novel Parvovirus and Related Variant in Human Plasma
por: Fryer, Jacqueline F., et al.
Publicado: (2006)

The Relationship Between SARS-CoV-2 Neutralizing Antibody Titers and Avidity in Plasma Collected From Convalescent Nonvaccinated and Vaccinated Blood Donors
por: Nurmi, Visa, et al.
Publicado: (2023)

Evidence of HIV pre-exposure or post-exposure prophylaxis (PrEP/PEP) among blood donors: a pilot study, England June 2018 to July 2019
por: Harvala, Heli, et al.
Publicado: (2022)

Genetic characterization of human coxsackievirus A6 variants associated with atypical hand, foot and mouth disease: a potential role of recombination in emergence and pathogenicity
por: Gaunt, Eleanor, et al.
Publicado: (2015)

Convalescent plasma donors show enhanced cross‐reactive neutralizing antibody response to antigenic variants of SARS‐CoV‐2 following immunization
por: Harvala, Heli, et al.
Publicado: (2022)

Novel Parvoviruses from Wild and Domestic Animals in Brazil Provide New Insights into Parvovirus Distribution and Diversity
por: de Souza, William Marciel, et al.
Publicado: (2018)

Comparability of six different immunoassays measuring SARS‐CoV‐2 antibodies with neutralizing antibody levels in convalescent plasma: From utility to prediction
por: Lamikanra, Abigail, et al.
Publicado: (2021)

Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials
por: Shankar-Hari, Manu, et al.
Publicado: (2020)

Voluntary Unpaid Plasma Donation
por: Pourfathollah, Ali Akbar, et al.
Publicado: (2023)

Viral Load Distribution in SARS Outbreak
por: Chu, Chung-Ming, et al.
Publicado: (2005)

CpG Distribution and Methylation Pattern in Porcine Parvovirus
por: Tóth, Renáta, et al.
Publicado: (2013)

Measles viral load may reflect SSPE disease progression
por: Kühne Simmonds , M, et al.
Publicado: (2006)

Specific protein content of pools of plasma for fractionation from different sources: impact of frequency of donations
por: Laub, R, et al.
Publicado: (2010)

Comparison of Alere q whole blood viral load with DBS and plasma viral load in the classification of HIV virological failure
por: Khan, Aabida, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jnn3hbjob99qfu7ff03cemeqjn